Biofilm Development and Approaches to Biofilm Inhibition by Exopolysaccharides

: Bacteria biofilm consists of microorganisms, accounting for 5-35% of the biofilm volume, and of the extracellular matrix (65-95%), made of water (97%), proteins (2%), polysaccharides (1-2%) and nucleic acids (DNA/RNA, both <1%). The physiology of bacteria in the biofilms entails adaptive changes with expression of genes which are different from those translated in the planktonic state. While most of our applied knowledge on bacterial biology stems from the study in the planktonic state, an increasing interest is currently paid to bacterial behaviour as biofilm generators, as it is estimated that 65% of all bacterial infections are associated with bacterial biofilms. Infections of both upper and lower airways, bacterial endocarditis, chronic otitis media, urinary tract infections, periodontitis, ocular infections and chronic wound infections (including diabetic foot ulcer) are all associated with biofilm formation. The role of biofilm is also relevant in case of infections taking place on abiotic surfaces, as in the case of infections occurring on prostheses and several other medical devices. Here, we review current knowledge on biofilm formation and its impact on human infections, discussing recent means for its inhibition, with particular emphasis on an interesting anti-biofilm activity exerted by exopolysaccharides derived from marine strains of Bacillus licheniformis.